CoraLite®594-conjugated L2HGDH Monoclonal antibody

L2HGDH Monoclonal Antibody for IF-P
Cat No. CL594-66269

产品说明书

CloneNo. 3D11C2

宿主/亚型

Mouse / IgG2a

种属反应性

human, pig

应用

IF-P

C14orf160, DURANIN, FLJ12618, L2HGDH

缓冲液配方:  PBS and Azide
PBS and Azide
规格: 

-/ -


经过测试的应用

Positive IF-P detected inhuman breast cancer tissue
For other applications, we recommend the unconjugated version of this antibody, 66269-1-Ig

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL594-66269 targets L2HGDH in IF-P applications and shows reactivity with human, pig samples.

经测试应用 IF-P Application Description
经测试反应性 human, pig
免疫原 L2HGDH fusion protein Ag8382 种属同源性预测
宿主/亚型 Mouse / IgG2a
抗体类别 Monoclonal
产品类型 Antibody
全称 L-2-hydroxyglutarate dehydrogenase
别名 C14orf160, DURANIN, FLJ12618, L2HGDH
计算分子量463aa,50 kDa; 441aa,49 kDa
观测分子量 45 kDa
GenBank蛋白编号BC006117
基因名称 L2HGDH
Gene ID (NCBI) 79944
RRIDAB_2919974
偶联类型 CoraLite®594 Fluorescent Dye
最大激发/发射波长588 nm / 604 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ9H9P8
储存缓冲液 PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

L2HGDH(L-2-hydroxyglutarate dehydrogenase, mitochondrial) is also named as duranin, C14orf160 and belongs to the L2HGDH family. The putative L2HGDH is predicted to be targeted to the mitochondria where its mitochondrial targeting sequence is presumably removed(PMID:16005139). Defects in L2HGDH are the cause of L-2-hydroxyglutaric aciduria (L2HGA). It has 2 isoforms produced by alternative splicing with the molecular weight of 50 kDa and 48 kDa. L2HGDH also can be detected as ~45kD due to the 51aa transit peptide cleaved.

实验方案

Product Specific Protocols
IF protocol for CL594 L2HGDH antibody CL594-66269Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...